CD55 and Miyoshi myopathy: Blocking CD55 and in particular CD59 increased in vitro CDC of acute lymphoblastic leukemia, MM, and sarcoma cells induced by alemtuzumab, daratumumab, rituximab, and anti-CD24, respectively [79,80,81].